iCoreConnect Inc. - ICCT STOCK NEWS

iCoreConnect Inc. (NASDAQ: ICCT) has announced a new partnership with the Alaska Dental Society (ADS), which has endorsed nine of iCoreConnect's products. This endorsement expands iCoreConnect's presence nationally, bringing its total to over 160 product endorsement agreements across various states. The endorsed products include solutions for insurance verification, ePrescribing, ICD-10 coding, dental claims and billing, practice analytics, patient education, and HIPAA-compliant email.

The partnership aligns with ADS's commitment to supporting its members with resources that enhance clinical practice and business operations. iCoreConnect's involvement in continuing education and practice management support provides access to approximately 155,000 dental professionals across the country, offering significant lead generation opportunities and an effective distribution channel for current and future products.

iCoreConnect Inc. (NASDAQ: ICCT) has announced a strategic partnership with DSO MarketWatch, a leading business intelligence provider in the dental industry. This collaboration aims to expand iCoreConnect's presence in the Dental Service Organization (DSO) sector. The partnership grants iCoreConnect access to DSO MarketWatch's extensive network of over 2,700 DSOs, dental group practices, and 150,000+ solo-practicing dentists.

Key benefits of this partnership include:

• Enhanced revenue growth opportunities for iCoreConnect
• Access to the DSO Directory with nearly 3,000 group practice accounts and 23,000 key contacts
• Increased lead generation, marketing, and sales outreach
• Promotion of iCorePay, a digital billing and payment platform tailored for DSOs

This collaboration is expected to significantly extend iCoreConnect's reach in the DSO market and provide valuable solutions to dental practices nationwide.

iCoreConnect Inc. (NASDAQ: ICCT) reported strong financial results for Q2 2024, with a 66% revenue increase to $3.1 million. The company saw improved gross profit margins, rising from 74% to 80%. iCoreConnect experienced high customer demand, including for its new Fintech product, iCorePay. The company implemented AI in its support division and is testing it across various solutions.

Operating expenses increased due to a one-time $4.8 million charge related to stock-based compensation. iCoreConnect expanded channel relationships and successfully restructured approximately $3.6 million in debt, extending maturities to August 1, 2027. This restructuring aims to improve cash flow management and support growth initiatives.

iCoreConnect Inc. (NASDAQ: ICCT) has announced a new reseller agreement with mConsent, a leader in digital patient engagement solutions. This partnership allows mConsent to offer iCoreRx, iCoreConnect's premier electronic prescribing software, as part of its suite of digital solutions for dental practices.

The collaboration aims to enhance mConsent's Patient Engagement Platform by integrating iCoreRx, which is designed to streamline prescription workflows and improve patient safety. iCoreRx offers features such as real-time drug interaction checks, automatic updates, and integration with various practice management systems.

This strategic partnership is expected to expand the reach of iCoreRx and provide dental professionals with a more comprehensive set of tools to improve efficiency and patient care.

iCoreConnect Inc. announced a new state endorsement from the Tennessee Dental Association for seven of its solutions, enabling the company's entry into the Tennessee market. The collaboration aims to enhance integration, expand functionality, provide unmatched support, and offer flexibility to TDA members. This strategic move underscores iCore's commitment to delivering innovative solutions tailored to customer needs and driving business growth.

iCoreConnect Inc. (ICCT) announces a significant OEM partnership with Carestream Dental to launch Rx Manager for Sensei, enhancing workflow productivity and customer profitability. The partnership integrates iCoreConnect's cloud software with Carestream Dental's Sensei portfolio, offering streamlined workflow, improved user experience, and enterprise scalability.

iCoreConnect Inc. announces two new endorsements from the Michigan Dental Association for its products iCoreCodeGenius and iCoreClaims, aiming to enhance clinical workflow efficiency and business profitability. The collaboration signifies iCore's commitment to delivering tailored solutions to meet customer needs and foster growth.

iCoreConnect, Inc. (NASDAQ: ICCT) announces significant enhancements to its iCoreCodeGenius Software as a Service (SaaS) offering, tailored for healthcare professionals. The update includes advanced coding capabilities, an enhanced user interface, improved integration options, enhanced performance, security features, and scalability to meet the evolving needs of healthcare businesses.

iCoreConnect Inc. (NASDAQ: ICCT) announced the expansion of its collaboration with the Rhode Island Dental Association, adding seven new endorsements of its offerings. The expanded collaboration reflects the value seen in iCore's solutions by the members of the association and the demand for its offerings in the dental industry. This strategic move aligns with iCore's mission to provide innovative solutions and advanced technologies that cater to the evolving needs of customers and state association members. The collaboration will help the Rhode Island Dental Association and its members leverage iCoreConnect’s comprehensive suite of SaaS solutions, empowering businesses with the tools and capabilities they need to succeed in an ever-changing marketplace.